Has Wesley Lackey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $115,048 in general payments to Wesley Lackey, MD across 112 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wesley Lackey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wesley Lackey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wesley Lackey, MD

Orthopaedic Surgery · Indianapolis, INNPI 1033314984

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (36.4%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 61.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $68,174 and has fallen 90.2% since, to $6,680 in 2025. Among orthopaedic surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,048in general payments, 2019–2025

Across 112 payments — averaging $1027.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$71K
Encore Medical, LP$24K
Total Joint Orthopedics, Inc.$20K
Engage Uni, LLC$185
Stryker$129
Zimmer Biomet$72
plus $130 from 4 others

$409,149in research payments, 2019–2025

Across 40 payments — averaging $10,229 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Zimmer Biomet$364K
Smith+Nephew$45K

What the payments were for

Royalty or licence$26,48323%
Consulting fees$34,88830%
Speaking & faculty fees$41,91536%
Travel & lodging$8,4757%
Food & beverage$3,1733%
Gifts$1140%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	53	$70,735
Encore Medical, LP	13	$23,803
Total Joint Orthopedics, Inc.	30	$19,993
Engage Uni, LLC	2	$185
Stryker	4	$129
Zimmer Biomet	1	$72
Amgen(2 entities)	5	$65
Pacira Pharmaceuticals Incorporated	2	$38
Dynasplint Systems Inc.	1	$15
EMD Serono, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,048 in reported general payments places this provider in the 90th percentile of 400 orthopaedic surgery providers in Indiana.

See all orthopaedic surgery providers in Indiana →

Medicare billing

Part B allowed, 2024

$291,735

Medicare patients

491

Services billed

7,738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Monohydrate	18	$1,048
Diclofenac Sodium	30	$648
Tranexamic Acid	105	$519
Cephalexin	19	$323
Methylprednisolone	24	$89
Meloxicam	42	$70
Amoxicillin	40	$51

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Indianapolis

David FisherIndianapolis$5.9M
Michael BerendIndianapolis$4M
Sanford KunkelIndianapolis$1.9M
Hill HastingsIndianapolis$1.6M
Michael CrossIndianapolis$870K
Brian MullisIndianapolis$632K
Dean MaarIndianapolis$589K
Russell SwannIndianapolis$135K
Thomas FischerIndianapolis$117K
Mark DillonIndianapolis$98K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →